Medicare Enrolled
Dr. Sharon Yegiaian, M.D.
Student in an Organized Health Care Education/Training Program · Pasadena, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yegiaian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yegiaian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yegiaian
Dr. Sharon Yegiaian is a student in an organized health care education/training program specialist in Pasadena, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Yegiaian performed 13,805 Medicare services across 2,965 unique beneficiaries.
Between the years covered by Open Payments, Dr. Yegiaian received a total of $37,378 from 60 pharmaceutical and/or device companies across 323 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yegiaian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 1% volume in CA
$37,378 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,805
Medicare services
Top 1% in CA for student in an organized health care education/training program
2,965
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~767 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
4,475 | $5 | $10 |
| Principal care management for high-risk disease, first 30 minutes This service involves 30 minutes of personal care management by a qualified healthcare professional for a patient with a single high-risk disease, billed per calendar month. |
2,269 | $68 | $180 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,589 | $51 | $100 |
| Telephone or electronic consultation, at least 5 minutes A remote assessment and management service provided by a consulting physician via telephone, internet, or electronic health record. The service requires at least 5 minutes of time and includes a written report. |
1,122 | $28 | $50 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,020 | $144 | $360 |
| Online digital E/M service, established patient, 21+ minutes An online digital evaluation and management service for an established patient. This service requires a total time of 21 or more minutes over a period of up to 7 days. |
915 | $39 | $260 |
| Online digital E/M service, established patient, 11-20 min An online digital evaluation and management service for an established patient. The service involves a total time of 11 to 20 minutes over a period of up to 7 days. |
613 | $25 | $80 |
| Telephone or internet referral service, 30 minutes A 30-minute service conducted via telephone or internet to arrange a referral for medical care. |
546 | $27 | $80 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
182 | $100 | $320 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
153 | $74 | $230 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
143 | $90 | $188 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
114 | $48 | $120 |
| New patient office visit, complex (60-74 min) | 103 | $160 | $480 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
60 | $96 | $260 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
56 | $37 | $400 |
| Needle electromyography of trunk or head muscles A test that uses a needle electrode to measure the electrical activity of muscles in the trunk or head. This helps evaluate muscle and nerve function. |
42 | $77 | $160 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
34 | $177 | $488 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
32 | $46 | $500 |
| Self-measured blood pressure monitoring The patient measures their own blood pressure at home using a monitoring device. This process allows for tracking blood pressure levels outside of a clinical setting. |
29 | $13 | $80 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 25 | $73 | $220 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $111 | $460 |
| Punch biopsy of additional skin growth A small circular tool is used to remove a sample of an extra skin growth for laboratory examination. |
24 | $55 | $140 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $79 | $260 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
20 | $133 | $650 |
| Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth | 20 | $35 | $120 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
19 | $58 | $250 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
18 | $249 | $662 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
16 | $13 | $80 |
| Electromyography of 2 extremities A test that measures the electrical activity in the muscles of two arms or legs. It helps evaluate nerve and muscle function. |
15 | $146 | $388 |
| EEG brain wave test, 61-119 minutes This procedure measures electrical activity in the brain using electrodes placed on the scalp. It records brain wave patterns for a duration between 61 and 119 minutes. |
14 | $405 | $1,248 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
14 | $81 | $240 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $51 | $96 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
13 | $114 | $302 |
| Psychological or neuropsychological test, first 30 minutes Administration of psychological or neuropsychological testing for the first 30 minutes. |
13 | $38 | $90 |
| EEG brain wave monitoring, 41-60 minutes This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes. |
12 | $312 | $988 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
12 | $21 | $54 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
11 | $159 | $404 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$37,378
Total received (2018-2024)
Avg $5,340/year across 7 years
Top 1% in CA for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
323
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$25,990 (69.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,219 (19.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,169 (11.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,363
2023
$1,005
2022
$819
2021
$3,019
2020
$3,880
2019
$18,570
2018
$8,721
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$266
Merz Pharmaceuticals, LLC
$182
Amneal Pharmaceuticals LLC
$77
Neurelis, Inc.
$76
Lilly USA, LLC
$71
Biogen, Inc.
$61
Neurocrine Biosciences, Inc.
$60
Kyowa Kirin, Inc.
$58
Alnylam Pharmaceuticals Inc.
$53
Grifols USA, LLC
$52
ARGENX US, INC.
$51
REVANCE THERAPEUTICS, INC.
$51
Genentech USA, Inc.
$50
AstraZeneca Pharmaceuticals LP
$42
Boston Scientific Corporation
$36
MDD US Operations, LLC
$31
CSL Behring
$31
Currax Pharmaceuticals LLC
$30
Eisai Inc.
$28
PFIZER INC.
$20
Amgen Inc.
$18
Alexion Pharmaceuticals, Inc.
$18
Top 3 companies account for 38.6% of 2024 payments
All-time payments by company (2018-2024) ›
CSL Behring
$18,985
Lundbeck LLC
$6,833
Alnylam Pharmaceuticals Inc.
$2,551
Akcea Therapeutics, Inc.
$2,099
Teva Pharmaceuticals USA, Inc.
$890
Merz Pharmaceuticals, LLC
$477
Alexion Pharmaceuticals, Inc.
$454
Neurocrine Biosciences, Inc.
$412
Genentech USA, Inc.
$339
Amgen Inc.
$247
Amneal Pharmaceuticals LLC
$234
Biogen, Inc.
$231
Supernus Pharmaceuticals, Inc.
$226
Kyowa Kirin, Inc.
$220
Avanir Pharmaceuticals, Inc.
$192
Strongbridge US INC.
$186
Horizon Therapeutics plc
$169
Medtronic, Inc.
$162
GENZYME CORPORATION
$161
Neurelis, Inc.
$155
ARBOR PHARMACEUTICALS, INC.
$148
Acorda Therapeutics, Inc
$144
CATALYST PHARMACEUTICALS, INC.
$125
ACADIA Pharmaceuticals Inc
$115
US WorldMeds, LLC
$114
MDD US Operations, LLC
$107
Grifols USA, LLC
$98
Lilly USA, LLC
$95
ARGENX US, INC.
$79
Allergan Inc.
$71
Novartis Pharmaceuticals Corporation
$69
Currax Pharmaceuticals LLC
$65
Merz North America, Inc.
$64
Allergan, Inc.
$64
Grifols Shared Services North America, Inc.
$58
Sunovion Pharmaceuticals Inc.
$55
REVANCE THERAPEUTICS, INC.
$51
Neuronetics, Inc.
$45
Arbor Pharmaceuticals, Inc.
$44
AstraZeneca Pharmaceuticals LP
$42
IMPEL PHARMACEUTICALS INC.
$41
Upsher-Smith Laboratories LLC
$41
AbbVie Inc.
$41
Assertio Therapeutics, Inc.
$39
Boston Scientific Corporation
$36
Catalyst Pharmaceuticals, Inc.
$33
Eisai Inc.
$28
Biohaven Pharmaceuticals, Inc.
$27
Otsuka America Pharmaceutical, Inc.
$26
Medtronic Vascular, Inc.
$24
Sarepta Therapeutics, Inc.
$22
PFIZER INC.
$20
MITSUBISHI TANABE PHARMA AMERICA, INC.
$19
Octapharma USA, Inc.
$17
ABBVIE INC.
$17
Scilex Pharmaceuticals Inc.
$16
Avion Pharmaceuticals
$16
Banner Life Sciences, LLC
$15
Xeris Pharmaceuticals, Inc.
$14
AbbVie, Inc.
$12
Top 3 companies account for 75.9% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · APOKYN · APTIOM · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · CAMBIA · CONTRAVE · CREXONT · Cambia · DAXI · DAXXIFY · DISEASE STATE · Dhivy · Duopa · EXONDYS 51 · Edarbi · Edarbyclor · FIRDAPSE · GILENYA · GIVLAARI · GOCOVRI · GVOKE PFS · Gamunex-C · Gocovri · Gralise · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LINQ II · LINZESS · Leqembi · MyCareLink · NEUROSTAR TMS THERAPY SYSTEM · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · ONZETRA XSAIL · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · POMPE - DISEASE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · RYTARY · SKYCLARYS · SOLIRIS · SPINRAZA · TEGSEDI · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VYVGART · VYVGART HYTRULO · WAINUA · XEOMIN · Xeomin · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (70%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in student in an organized health care education/training program and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for student in an organized health care education/training program in CA.
Geographic Context
Student in an organized health care education/training programs within 10 mi
15,326
Per 100K population
155.6
County median income
$87,760
Nearest hospital
AURORA LAS ENCINAS
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Yegiaian is a clinical cardiology specialist, with above-average Medicare volume (top 1% in CA), with speaking/promotional industry engagement in the top 1% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Yegiaian experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Yegiaian performed 4,475 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yegiaian receive payments from pharmaceutical companies?
Yes. Dr. Yegiaian received a total of $37,378 from 60 companies across 323 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yegiaian's costs compare to other student in an organized health care education/training programs in Pasadena?
Dr. Yegiaian's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yegiaian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Pasadena
Browse student in an organized health care education/training programs in Pasadena ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in CA
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in CA
Which CA student in an organized health care education/training programs receive the most from drug and device companies.
By company
CSL Behring Payments to Doctors
See all physicians who received payments from CSL Behring.
By company
Lundbeck LLC Payments to Doctors
See all physicians who received payments from Lundbeck LLC.
By company
Alnylam Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Alnylam Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology